Findings of a 1303 Korean whole-exome sequencing study

Experimental and Molecular Medicine

Volumn 49, Issue 7, 2017, Pages

  Kwak, Soo Heon ^a   Chae, Jeesoo ^b   Choi, Seongmin ^a   Kim, Min Jung ^b   Choi, Murim ^b   Chae, Jong Hee ^b   Cho, Eun Hae ^c   Hwang, Tai Ju ^d   Jang, Se Song ^b   Kim, Jong Il ^b   Park, Kyong Soo ^a,b,e   Bang, Yung Jue ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Green Cross Corporation   (South Korea)

^d Korean Hemophilia Foundation Clinic   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 6;

ARTICLE; GENETIC VARIATION; HETEROZYGOSITY; HUMAN; INDEL MUTATION; POPULATION STRUCTURE; PRINCIPAL COMPONENT ANALYSIS; SEGMENTAL DUPLICATION; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREAN; WHOLE EXOME SEQUENCING; ASIAN CONTINENTAL ANCESTRY GROUP; EXOME; FEMALE; FRAMESHIFT MUTATION; GENE LOCUS; GENETICS; HIGH THROUGHPUT SEQUENCING; MALE; SOUTH KOREA; STATISTICAL ANALYSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; DATA INTERPRETATION, STATISTICAL; EXOME; FEMALE; FRAMESHIFT MUTATION; GENETIC LOCI; GENETIC VARIATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; WHOLE EXOME SEQUENCING;

EID: 85041058354     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2017.142     Document Type: Article

References (31)

1. Collins FS, Hamburg MA. First FDA authorization for next-generation sequencer. N Engl J Med 2013; 369: 2369–2371.
2. Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 2014; 312: 1870–1879.
3. Fuchsberger C, Flannick J, Teslovich TM, Mahajan A, Agarwala V, Gaulton KJ et al. The genetic architecture of type 2 diabetes. Nature 2016; 536: 41–47.
4. The 1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM et al. A global reference for human genetic variation. Nature 2015; 526: 68–74.
5. Fu W, O’Connor TD, Jun G, Kang HM, Abecasis G, Leal SM et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 2013; 493: 216–220.
6. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016; 536: 285–291.
7. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013; 15: 565–574.
8. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405–423.
9. Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD et al. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet 2016; 98: 1067–1076.
10. Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, Gallego CJ et al. Actionable, pathogenic incidental findings in 1000 participants’ exomes. Am J Hum Genet 2013; 93: 631–640.
11. Amendola LM, Dorschner MO, Robertson PD, Salama JS, Hart R, Shirts BH et al. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res 2015; 25: 305–315.
12. Maxwell KN, Hart SN, Vijai J, Schrader KA, Slavin TP, Thomas T et al. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer. Am J Hum Genet 2016; 98: 801–817.
13. Jang M-A, Lee S-H, Kim N, Ki C-S. Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes. Genet Med 2015; 17: 1–5.
14. Gambin T, Jhangiani SN, Below JE, Campbell IM, Wiszniewski W, Muzny DM et al. Secondary findings and carrier test frequencies in a large multiethnic sample. Genome Med 2015; 7: 54.
15. Fuentes Fajardo KV, Adams DProgram NCS, Mason CE, Sincan M, Tifft C et al. Detecting false-positive signals in exome sequencing. Hum Mutat 2012; 33: 609–613.
16. Adams DR, Sincan M, Fuentes Fajardo K, Mullikin JC, Pierson TM, Toro C et al. Analysis of DNA sequence variants detected by high-throughput sequencing. Hum Mutat 2012; 33: 599–608.
17. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754–1760.
18. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20: 1297–1303.
19. Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA et al. The variant call format and VCFtools. Bioinformatics 2011; 27: 2156–2158.
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
21. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: e164.
22. Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 2014; 133: 1–9.
23. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 2014; 42: D980–D985.
24. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 2015; 4: 7.
25. Alexander DH, Novembre J, Lange K. Fast model-based estimation of ancestry in unrelated individuals. Genome Res 2009; 19: 1655–1664.
26. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011; 88: 76–82.
27. Agresti A, Coull BA. Approximate is better than ‘exact’ for interval estimation of binomial proportions. Am Stat 1998; 52: 119–126.
28. Tukey JW. Exploratory Data Analysis: Past, Present and Future. Defense Technical Information Center; Fort Belvoir, VA, USA, 1993.
29. Wong LP, Lai JK, Saw WY, Ong RT, Cheng AY, Pillai NE et al. Insights into the genetic structure and diversity of 38 South Asian Indians from deep whole-genome sequencing. PLoS Genet 2014; 10: e1004377.
30. Wong LP, Ong RT, Poh WT, Liu X, Chen P, Li R et al. Deep whole-genome sequencing of 100 southeast Asian Malays. Am J Hum Genet 2013; 92: 52–66.
31. Lim ET, Wurtz P, Havulinna AS, Palta P, Tukiainen T, Rehnstrom K et al. Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet 2014; 10: e1004494.